Medicina
Departamento
Hospital Universitario San Juan de Alicante
San Juan de Alicante, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario San Juan de Alicante (12)
2020
-
Recommendations for specialized nutritional-metabolic management of the critical patient: introduction, methodology and list of recommendations. Metabolism and Nutrition Working Group of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)
Medicina Intensiva, Vol. 44, pp. 1-14
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85
2009
-
Sustained ventricular arrhythmias in unstable angina patients: Results of the ARIAM database
Medical Science Monitor, Vol. 15, Núm. 6
2007
-
Risk factors for candidaemia in critically ill patients: A prospective surveillance study
Mycoses, Vol. 50, Núm. 4, pp. 302-310
2006
-
Bloqueo auriculoventricular en la angina inestable. Resultados del registro ARIAM
Medicina Intensiva, Vol. 30, Núm. 9, pp. 432-439
2005
-
Estudio multicéntrico de incidencia de las complicaciones de la nutrición enteral total en el paciente grave. Estudio ICOMEP 2
a
parte
Nutricion Hospitalaria, Vol. 20, Núm. 4, pp. 278-285
-
Estudio multicéntrico de incidencia de las complicaciones de la nutrición parenteral total en el paciente grave. Estudio ICOMEP 1
a
parte
Nutricion Hospitalaria, Vol. 20, Núm. 4, pp. 268-277
-
Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma
Cancer Chemotherapy and Pharmacology, Vol. 55, Núm. 2, pp. 197-202
2004
-
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: Results of a large, multicentre phase II study
Cancer Chemotherapy and Pharmacology, Vol. 53, Núm. 1, pp. 75-81